Semaglutide vs Tirzepatide: Which GLP-1 Is Better for Weight Loss?

Head-to-Head: Semaglutide vs Tirzepatide

Weight Loss Efficacy

Semaglutide (SURMOUNT trials): Average weight loss of 15-18% of body weight at the highest dose (2.4mg weekly). In the largest trial, patients lost an average of 18kg over 68 weeks.

Tirzepatide (SURMOUNT trials): Average weight loss of 20-22% of body weight at the highest dose (15mg weekly). In the highest-dose arm, patients lost an average of 22.5kg over 68 weeks.

What this means: Tirzepatide wins on the numbers. But the gap is 3-4kg average difference — and individuals vary. Someone losing 20% on semaglutide is common; someone plateauing at 10% is also real. Response is personal.

Blood Sugar Control (HbA1c Reduction)

Semaglutide: HbA1c reduction of 1.5-1.8% in Type 2 diabetics, depending on baseline and dose.

Tirzepatide: HbA1c reduction of 2.0-2.5% in Type 2 diabetics at the same baseline. Dual GIP+GLP-1 activation is superior for insulin secretion.

If you have Type 2 diabetes, tirzepatide's advantage is real. If you're just doing weight loss without diabetes, the difference matters less.

Dosing Schedule

Both are weekly injections. Semaglutide starts at 0.25mg weekly and titrates every 4 weeks up to 1.0mg, 1.5mg, or 2.4mg weekly. Tirzepatide starts at 2.5mg weekly and titrates up to 5mg, 7.5mg, 10mg, 12.5mg, or 15mg weekly. Most people find a "sweet spot" dose — the lowest dose that gives good weight loss with tolerable side effects — rather than maxing out.

Side Effects Profile

Shared side effects (both GLP-1 and tirzepatide): Nausea, vomiting, constipation, diarrhea, abdominal pain. These are worst in weeks 1-4 of a new dose, then usually improve. Most people adapt within 4-6 weeks.

Tirzepatide-specific: May have slightly higher initial nausea because it hits two pathways. Some users report worse constipation. This is anecdotal — trial data shows similar tolerability rates.

Rare serious side effects (both): Pancreatitis (acute and chronic), thyroid C-cell tumors (theoretical, based on animal studies — no human cases proven). Anyone with personal or family history of medullary thyroid cancer cannot use either.

Muscle loss: Both GLP-1 agonists accelerate weight loss, and some of that weight is muscle. Rapid weight loss without strength training can mean 25-30% of weight lost is lean mass. Your muscles shrink. Your metabolism slows. You need: (1) Resistance training 3-4x weekly, (2) High protein (1.6-2.2g per kg body weight), (3) Calorie deficit, but not extreme.

Indian Availability and Cost

Semaglutide in India

Availability: Yes. Ozempic (1.0mg/1.5mL pen, weekly injection) is available through Novo Nordisk in India. Originally approved for Type 2 diabetes; increasingly prescribed off-label for weight loss. Rybelsus (oral semaglutide, 3mg, 7mg, 14mg tablets) is also available but less common for weight loss.

Cost: 8,000-12,000 INR per 1.0-1.5mg pen (one pen = 4 weeks of treatment). Generic versions are beginning to emerge but are still limited. If you're cost-sensitive, semaglutide + generics (when available) is the cheaper option.

Supply: Consistent. Novo Nordisk is established in India.

Tirzepatide in India

Availability: Mounjaro (Eli Lilly) was approved by Indian regulatory authorities in late 2024-early 2025. However, supply is inconsistent, and availability is limited. Some cities have it; others don't. Availability may depend on hospital formularies and private sourcing.

Cost: 10,000-15,000 INR per injection (estimated based on current pricing; exact cost varies). When available, it's slightly more expensive than semaglutide.

Supply: Currently inconsistent. Eli Lilly is scaling production, but tirzepatide is newer globally and supply lags demand. Your arq. physician will check current availability before prescribing.

The practical reality: If you want tirzepatide now in India, you may face sourcing challenges. Semaglutide is more reliably available. arq. will prescribe based on current Indian availability, not just what's ideal in theory.

Who Should Choose Which?

Choose Semaglutide If:

• You have Type 2 diabetes and weight loss is secondary — semaglutide has more long-term diabetes data in India
• Cost is a major factor — semaglutide is slightly cheaper and generics may emerge sooner
• You want a reliably available option right now — Ozempic supply is consistent in India
• Your metabolic profile suggests you'll respond well (your arq. physician will assess)
• You've used it before or know you tolerate it well

Choose Tirzepatide If:

• Pure weight loss is your goal and maximum efficacy matters — tirzepatide shows stronger weight loss in trials
• You have Type 2 diabetes and need maximum HbA1c reduction — tirzepatide's dual action is superior
• You've tried semaglutide and didn't lose enough weight — switching to tirzepatide may work
• Tirzepatide is reliably available in your location (check with arq.)
• You can tolerate potentially higher initial nausea

What If One Doesn't Work?

Some people don't respond well to one but do to the other. If you lose <5% on semaglutide after 3 months, your arq. physician may switch you to tirzepatide. If tirzepatide causes intolerable nausea, switching to semaglutide is reasonable. You're not locked into one forever — it's about finding what works for your body.

Why Bloodwork Before Starting (And Throughout)

Both medications affect multiple organs. Pre-prescription bloodwork is mandatory at arq. Here's why:

Pancreas Function

Amylase, lipase, pancreatic enzymes: Pancreatitis (inflammation of the pancreas) is rare but serious. Baseline values let your physician detect early trouble. If you already have chronic pancreatitis or severe pancreatic disease, these medications are contraindicated.

Kidney Function

Creatinine, eGFR, urinalysis: GLP-1 agonists affect renal hemodynamics (blood flow in the kidneys). If you have advanced kidney disease, dosing needs adjustment. GI side effects (vomiting, diarrhea) can dehydrate you, stressing kidneys further.

Liver Function

AST, ALT, GGT, bilirubin: Rapid weight loss stresses the liver. If you have fatty liver disease or cirrhosis, your liver needs monitoring. Some weight loss medications can worsen liver inflammation.

Thyroid and Cancer Risk

TSH, free T4, thyroid ultrasound if nodules present: GLP-1 agonists carry a theoretical risk of thyroid C-cell tumors (medullary thyroid carcinoma). If you have a family history of medullary thyroid cancer, or a personal history of thyroid nodules, you likely can't use these medications. If you have Hashimoto's thyroiditis or other autoimmune thyroid disease, monitoring is needed.

Glucose Control

Fasting glucose, HbA1c, insulin: If you're already on insulin or sulfonylureas, these medications increase hypoglycemia risk (dangerously low blood sugar). Your doses may need adjustment. Baseline glucose helps your physician track this.

Electrolytes and Hydration

Sodium, potassium, magnesium, phosphate: GI side effects (vomiting, diarrhea) cause electrolyte loss. Baseline values let your physician catch imbalances early.

Baseline Weight, Blood Pressure, Heart Rate

Physical measurements: Weight loss affects blood pressure (usually improves). Heart rate may increase if weight loss is rapid. Baseline values are your reference.

Timeline: arq. checks these markers before starting, then again at 4-8 weeks, then monthly if needed. This is how you stay safe while losing weight aggressively.

The Muscle Loss Problem (And How to Fix It)

Here's what nobody talks about: when you take a GLP-1 agonist and lose weight fast, you lose both fat and muscle. Studies show 25-30% of weight lost can be lean mass, especially if you don't exercise or eat enough protein. Result: you get lighter but weaker, slower metabolism, and the weight comes back easily.

Why This Happens

Rapid weight loss from appetite suppression means you're eating less. If you don't eat enough protein, your body breaks down muscle for energy. Without resistance training, muscles atrophy. You lose fat, but you also lose the metabolic machinery.

How to Prevent It

Protein: Eat 1.6-2.2g of protein per kg of body weight daily. For a 80kg person, that's 130-180g daily. This is non-negotiable. Protein preserves muscle during weight loss.

Strength Training: 3-4 days per week. Resistance training (weights, bands, bodyweight) sends the signal to your muscles: "stay, you're needed." Without this signal, muscles shrink. Cardio alone isn't enough.

Calorie Deficit, But Not Extreme: Lose 0.5-1kg per week, not 2-3kg. Slow weight loss spares more muscle. Crash dieting + GLP-1 agonist = muscle loss disaster.

Micronutrients: Adequate iron, B12, Vitamin D, magnesium. Deficiencies accelerate muscle loss. Your arq. physician monitors these.

arq. will connect you with a dietitian who structures your eating plan around these principles. It's not just "eat less" — it's "eat strategically."

How arq. Prescribes Semaglutide and Tirzepatide (Differently)

Most weight loss clinics see you once, sell you the medication, and disappear. arq. is different.

arq.'s approach:

• Comprehensive metabolic assessment: Blood tests, metabolic panel, pancreas function, kidney function, liver function, thyroid, glucose, electrolytes, baseline weight
• Personalized choice: Based on your bloodwork, cost sensitivity, and Indian availability, your physician recommends semaglutide or tirzepatide (or both if trying one then switching)
• Slow titration: Start low (0.25mg semaglutide or 2.5mg tirzepatide), titrate every 4 weeks. Your sweet spot dose is the goal, not maximum dose
• Monthly monitoring: Check-in at 4 weeks, 8 weeks, then monthly. Bloodwork at 8-12 weeks to catch early issues
• Dietitian protocol: Personalized eating plan with enough protein, strength training prescription, muscle preservation focus
• Muscle loss prevention: Resistance training 3-4x weekly, protein targets, electrolyte monitoring
• Side effect management: If nausea is intolerable, slow your titration. If constipation is bad, add fiber and hydration. Don't suffer in silence — adjustments exist
• Switch flexibility: If semaglutide doesn't deliver after 3 months, switching to tirzepatide is straightforward. arq. doesn't lock you in.
• Indian supply reality: arq. knows what's available now. If Mounjaro supply breaks, we pivot to Ozempic without missing a beat

The core difference: You're not buying a medication. You're building a weight loss protocol that actually preserves your health and builds sustainable habits.